NACE:Postmenopausal Osteoporosis: Identifying and Managing Patients at High Risk of Fracture

CME Course Description

Speaker
Marjorie M. Luckey, MD

Speaker Affiliation
Medical Director, Osteoporosis Center
Saint Barnabas Medical Center
Livingston, NJ

Title:	Postmenopausal Osteoporosis: Identifying and Managing Patients at High Risk of Fracture
Activity/Course #:	NCME177
Cost:	Free
Release/Start Date:	Oct 01 2011
Expiration Date:	Sep 30 2013
Topics:	Primary Care Medicine
Target Audience:	Primary Care Providers
Medium/Method:	Webcast
Estimated Time To Complete CME Activity:	1.0 Hours
Hardware/Software Requirements:	Any web browser with media player
Credits:	1.0
Welcome to the National Association for Continuing Education webcast from the NACE Emerging Challenges in Primary Care Update: 2011 conference. The topic of this webcast is Postmenopausal Osteoporosis: Identifying and Managing Patients at High Risk of Fracture. The program was captured live in Denver, Colorado on June 4, 2011 and features Dr. Majorie Luckey. Dr. Luckey is the Medical Director of the Osteoporosis Center at the Saint Barnabas Medical Center in Livingston, New Jersey. Learning Objective(s): After completing this program participants should be able to: Define screening strategies for osteoporosis in postmenopausal women identify candidates for pharmacologic treatment of postmenopausal osteoporosis Evaluate and compare available therapies for osteoporosis Recognize and overcome barriers to adherence and effectiveness of osteoporosis therapy This webcast was recorded live and is being used with the permission of the presenter. How To Obtain Your CME Certificate Register for the course at www.naceonline.com. View the content. Complete and submit the post-test and evaluation. A minimum passing score of 60% must be earned on the post-test in order to complete the CME activity. Print your CME certificate.
Accredited By National Association for Continuing Education
Accreditation Designation Statement The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The National Association for Continuing Education designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Faculty Disclosure Policy Marjorie M. Luckey, MD, Speaker, is a consultant for Amgen, Merck, Novartis, Tarsa and Eli Lilly and is a speaker for Amgen, Novartis. Gregg Sherman, MD, Course Director, has no relationships to disclose. Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose. Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose. Harvey Parker, PhD, Activity Planning Committee, has no relationships to disclose. Vernon Hershberger MD, FAAFP, Activity Planning Commitee, serves as a consultant to Amgen and Warner Chilcott; and he conducts contracted research for Pfizer, Ortho-McNeil, Sanofi-aventis, Boehringer Ingelheim, and Sepracor. Nelson B. Watts, MD, Activity Planning Committee serves as a speaker for Amgen, Novartis,and Warner Chilcott; a consultant for Amgen, Arena, Baxter, Imagepace, InteKrin, Johnson & Johnson, Lilly, Medpace, Merck, NPS, Orexigen, Pfizer/Wyeth, Takeda, Vivus and Warner Chilcott; and receives research support from Amgen, Merck, and NPS; Co-Founder, Stockholder and Director of OsteoDynamics None of the peer reviewers have any relevant financial relationships to disclose.
Commercial Support Amgen provided commercial support for this enduring activity.